Home » Stocks » BRKR

Bruker Corporation (BRKR)

Stock Price: $60.98 USD -1.81 (-2.88%)
Updated Feb 26, 2021 4:00 PM EST - Market closed
Market Cap 9.34B
Revenue (ttm) 1.96B
Net Income (ttm) 157.50M
Shares Out 153.20M
EPS (ttm) 1.02
PE Ratio 59.78
Forward PE 36.63
Dividend $0.16
Dividend Yield 0.26%
Trading Day February 26
Last Price $60.98
Previous Close $62.79
Change ($) -1.81
Change (%) -2.88%
Day's Open 62.96
Day's Range 60.80 - 63.40
Day's Volume 657,356
52-Week Range 30.70 - 69.92

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 2 days ago

MUNICH--(BUSINESS WIRE)--Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurement

Zacks Investment Research - 4 days ago

Within Bruker's (BRKR) Nano Group Semiconductor metrology revenues have been steady with order rates improving as semi metrology equipment markets are witnessing a rebound.

Business Wire - 5 days ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Present at Investor Conferences

Business Wire - 1 week ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Quarterly Dividend

Zacks Investment Research - 1 week ago

Bruker's (BRKR) revenues increased 4.6% year over year to $627.5 million but declined 0.4% organically in fourth-quarter fiscal 2020.

Business Wire - 1 week ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results

Benzinga - 1 week ago

Bruker (NASDAQ:BRKR) unveils its next round of earnings this Tuesday, February 16. Get prepared with Benzinga's ultimate preview for Bruker's Q4 earnings.

Zacks Investment Research - 2 weeks ago

Bruker (BRKR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Zacks Investment Research - 2 weeks ago

Bruker (BRKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 3 weeks ago

Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Business Wire - 3 weeks ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Date and Time of Fourth Quarter 2020 Earnings Release and Webcast

Business Wire - 4 weeks ago

CAMBRIDGE & WETHERBY, England & BILLERICA, Mass.--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, announces that it has entered into a co...

Zacks Investment Research - 1 month ago

4 Stocks to Watch on Rising Demand for Scientific Instruments

Other stocks mentioned: MTD, PKI, WAT
Business Wire - 1 month ago

BOSTON, United States & REGENSBURG, Germany--(BUSINESS WIRE)--NMR diagnostics company numares and Bruker Corporation sign agreement to enable advanced metabolomics-based, AI driven clinical di...

Business Wire - 1 month ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Present at the 39th Annual J.P. Morgan Healthcare Conference

Business Wire - 1 month ago

BILLERICA, Mass. & ODENSE, Denmark--(BUSINESS WIRE)--Bruker and Evosep Announce Major Progress in Unbiased, Quantitative True Single-cell Proteomics

Business Wire - 1 month ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Introduces MBT Sepsityper® Kit US IVD for Rapid and Affordable Identification of over 400 Microorganisms from Positive Blood Cultures

Zacks Investment Research - 2 months ago

Bruker's (BRKR) winter four-plex panel is expected to facilitate diagnosis and patient management by facilitating the use of saliva samples as well.

Business Wire - 2 months ago

NEHREN, Germany--(BUSINESS WIRE)--Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark

Zacks Investment Research - 2 months ago

Bruker (BRKR) is optimistic about maintaining a robust product portfolio along with its continued COVID-19-led progress.

Zacks Investment Research - 2 months ago

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?

Seeking Alpha - 2 months ago

For the month, there were 13 buys including two new positions. I made the month's purchases last Friday. With the market flying high, what bargains are out there now?

Other stocks mentioned: ABEV, AZPN, CBOE, DANOY, ED, ENB, FAF, FLIC, HRL, ITIC, JNJ, OVBC, ROP
Business Wire - 3 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Participate in the Jefferies Virtual London Healthcare Conference

Business Wire - 3 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Quarterly Dividend

Zacks Investment Research - 3 months ago

Bruker's (BRKR) third-quarter 2020 results reflect dismal performances by two of the reporting segments and geographies due to coronavirus-led business disruptions.

Seeking Alpha - 3 months ago

Bruker Corporation (BRKR) CEO Frank Laukien on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 3 months ago

Bruker (BRKR) delivered earnings and revenue surprises of 27.27% and 5.27%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Business Wire - 3 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Reports Third Quarter 2020 Financial Results

Benzinga - 3 months ago

On Monday, November 02, Bruker (NASDAQ: BRKR) will release its latest earnings report. Benzinga's outlook for Bruker is included in the following report.

Seeking Alpha - 3 months ago

We discuss the 13 stocks I added to my portfolio in October. I lay out the bull case for Northwest Natural as it trades near its highest dividend yield in 10 years.

Other stocks mentioned: CAAP, CBOE, CNQ, DANOY, DEO, ENB, JNJ, NWN, REYN, SU, TFSL, WMT
Zacks Investment Research - 4 months ago

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Business Wire - 4 months ago

MADISON, Wisc.--(BUSINESS WIRE)--Bruker Introduces Vutara™ VXL Best-in-Class Super-Resolution Microscope and Spatial Biology Analysis Capabilities

Business Wire - 4 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Date and Time of Third Quarter 2020 Earnings Release and Webcast

Business Wire - 4 months ago

ZUERICH--(BUSINESS WIRE)--Bruker Introduces Routine Gradient Spectroscopy and Industry-Standard PAL® Automation on High-Performance Fourier™ 80 Benchtop FT-NMR System

Business Wire - 4 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Introduces PaSER™ Software for ‘Run and Done' 4D- ProteomicsTM and TIMS/PASEF Method Wins HUPO 2020 Award

Zacks Investment Research - 4 months ago

Bruker (BRKR) has several Bruker NANO products that are being assembled and tested in Malaysia.

Business Wire - 4 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Acquisition of Integrated Proteomics Pipeline (IP2) Software Platform for Large Cohort Translational Studies

InvestorPlace - 4 months ago

The global trade winds are shifting. That should be good news for domestic industry, and these seven manufacturing stocks in particular.

Other stocks mentioned: CAT, GD, KBAL, MMM, SPR, WHR
Seeking Alpha - 5 months ago

13 stocks purchased this month, and 1 sale: JD.

Other stocks mentioned: CAAP, CNQ, FAF, GD, HII, WASH
Zacks Investment Research - 5 months ago

Bruker (BRKR) expands its multi-dimensional immune profiling by adding ChipCytometry tools via the acquisition of Canopy Biosciences.

Business Wire - 5 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Acquisition of Canopy Biosciences, LLC

Zacks Investment Research - 5 months ago

At Bruker's (BRKR) Germany campus, the company currently offers a pilot COVID-19 at work testing program for its factory workforce.

Zacks Investment Research - 5 months ago

4 Stocks to Watch on Rising Demand for Scientific Instruments

Other stocks mentioned: MTD, PKI, WAT
Business Wire - 5 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Appoints Bonnie H.

Business Wire - 5 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 2020 Wells Fargo Virtual Healthcare Conference.

Zacks Investment Research - 5 months ago

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 6 months ago

For higher specific detection of the SARS-CoV-2 virus, Bruker (BRKR) launches luoroType SARS-CoV-2 plus next-generation 6-plex PCR assay.

Business Wire - 6 months ago

FRANKFURT, Germany--(BUSINESS WIRE)--Bruker Supports International Covid19-NMR Consortium for Structure-Function and Inhibitor Binding Investigations of SARS-CoV-2 RNA and Proteins

Business Wire - 6 months ago

BILLERICA, Mass.--(BUSINESS WIRE)--Utrecht University and Bruker Announce Collaboration to Develop Methods for Studying Protein Structures and Interactions by Mass Spectrometry

Zacks Investment Research - 6 months ago

Bruker's (BRKR) second-quarter 2020 results reflect dismal performance by all segments and geographies due to coronavirus-led business disruptions.

About BRKR

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on infrared and Raman... [Read more...]

Industry
Medical Devices
IPO Date
Aug 4, 2000
CEO
Frank Laukien
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
BRKR
Full Company Profile

Financial Performance

In 2019, Bruker's revenue was $2.07 billion, an increase of 9.34% compared to the previous year's $1.90 billion. Earnings were $197.20 million, an increase of 9.74%.

Financial Statements

Analyst Forecasts

According to 13 analysts, the average rating for Bruker stock is "Buy." The 12-month stock price forecast is 65.42, which is an increase of 7.28% from the latest price.

Price Target
$65.42
(7.28% upside)
Analyst Consensus: Buy